Who Owns Zymeworks Stock?
NASDAQ: ZYMEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 104.41%
- Institutions (% of float)
- 106.01%
- Held by insiders
- 1.52%
- Institutional holders
- 301
- Institutions 98.5%
- Insiders 1.5%
- Public and other 0.0%
Who owns Zymeworks stock?
Institutional investors own about 104.4% of Zymeworks's shares, spread across 301 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.52% of ZYME.
The largest institutional holders are EcoR1 Capital, LLC (36.46%), Rubric Capital Management LP (11.11%) and Blackrock Inc. (6.69%). Together, the top 10 institutions control 81.3% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their ZYME positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ZYME
| Institution | Shares | % Held | Change |
|---|---|---|---|
| EcoR1 Capital, LLC | 22.97M | 36.46% | 0.0% |
| Rubric Capital Management LP | 7.00M | 11.11% | 0.0% |
| Blackrock Inc. | 4.21M | 6.69% | -0.9% |
| Perceptive Advisors Llc | 4.18M | 6.64% | +19.2% |
| BVF Inc. | 3.65M | 5.79% | -2.3% |
| Morgan Stanley | 3.24M | 5.14% | +45.1% |
| BNP Paribas Asset Management Holding S.A. | 1.78M | 2.83% | 0.0% |
| Vanguard Capital Management LLC | 1.56M | 2.47% | 0.0% |
| Assenagon Asset Management S.A. | 1.51M | 2.39% | +20.4% |
| Nextech Invest, Ltd. | 1.11M | 1.77% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ZYME
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.51M | 2.39% |
| iShares Trust-iShares Russell 2000 ETF | 1.19M | 1.88% |
| IVY FUNDS-Nomura Small Cap Growth Fund | 600.85K | 0.95% |
| iShares Trust-iShares Biotechnology ETF | 538.11K | 0.85% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 514.48K | 0.82% |
| iShares Trust-iShares Russell 2000 Growth ETF | 425.95K | 0.68% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 369.10K | 0.59% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 269.59K | 0.43% |
| BlackRock Funds-BlackRock Advantage Small Cap Core Fund | 239.66K | 0.38% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Portfolio | 194.46K | 0.31% |
Frequently asked questions
Who is the largest shareholder of Zymeworks?
EcoR1 Capital, LLC is the largest institutional shareholder of ZYME, owning 36.46% of shares outstanding (22.97M shares) as of its latest 13F filing.
What percentage of Zymeworks is owned by institutions?
Institutions own about 104.4% of ZYME shares and 106.0% of the public float.
How much of Zymeworks do insiders own?
Insiders, such as officers and directors, own about 1.52% of ZYME shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.